The Australian company led by former Novartis Australia head and Medicines Australia board member Fred Guerard is seeking to raise over $220 million to support its late-stage clinical trials. …
Opthea taps investors to raise almost $230 million to fund late-stage trials
June 12, 2024 Australian Biotech
Latest Video
New Stories
-
AbbVie announces new leadership for its New Zealand business
June 24, 2024 - - Latest News -
Report suggests significant funding boost for Pharmac
June 24, 2024 - - Latest News -
Joint submission recommends adjustments to minimum stockholding requirement
June 24, 2024 - - Latest News -
A legally questionable outcome but one that reveals the truth of this process
June 23, 2024 - - Latest News -
Oncology leadership transitions for MSD Australia and New Zealand
June 23, 2024 - - Latest News -
The 'Week in Review' Podcast - 21 June
June 21, 2024 - - Podcast -
MSD managing director departing to lead the company's Japan oncology business
June 21, 2024 - - Latest News